Tag: heart disease
-
EU Project to Develop More Versatile Heart Pacemakers
An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions.
-
Lilly Acquires Migraine Therapy Company in $960M Deal
Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms.
-
Pharma Firms Start Non-Communicable Disease Initiative
A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
Solar Cells Shown Feasible to Power Medical Implants
Biomedical engineers in Switzerland built and field-tested small solar cells that generated enough energy for implanted medical devices like heart pacemakers.
-
Trial to Test Stem Cells for Treating Heart Failure
A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites.
-
Genetic Tests, Elec. Health Records Show Hidden Disease
A program that connects mass genetic screening to electronic health records shows a segment of the population tested has an undiagnosed blood disorder causing high cholesterol levels.
-
Trial to Explore Microbiome Therapy for Hypertension
A clinical trial is set to begin that tests live bacteria as a treatment for hypertension, or high blood pressure, a condition affecting 1 in 3 adults in the U.S.
-
Project to Design Hybrid Stroke Imaging Technology
An alliance of academic and industry researchers in Europe is developing a single imaging device that can save valuable time in diagnosing a stroke.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.